Page last updated: 2024-10-25

eflornithine and Lymphatic Diseases

eflornithine has been researched along with Lymphatic Diseases in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stephan, C1
Just-Nuebling, G1
Fichtlscherer, S1
Kriener, S1
Brodt, HR1
Thomas, TJ1
Messner, RP1

Other Studies

2 other studies available for eflornithine and Lymphatic Diseases

ArticleYear
Winterbottom's sign and hypertrophic cardiomyopathy.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:7

    Topics: Adult; Animals; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Eflornithine; Humans; Lymphat

2002
Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice.
    Clinical and experimental immunology, 1989, Volume: 78, Issue:2

    Topics: Animals; Antibodies, Antinuclear; Biogenic Polyamines; DNA; Eflornithine; Enzyme Inhibitors; Female;

1989